title: Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies.
abstract: Vulvovaginitis is a common inflammatory condition that can significantly disrupt a woman's life. The term vulvovaginitis actually encompasses a variety of inflammatory lower gential tract disorders that may be secondary to infection, irritation, allergy or systemic disease (Table 1). This article focuses on candida-caused vulvovaginitis, a condition known as vulvovaginitis candidiasis. Approximately 75% of U.S. women expreience vulvovaginitis candidiasis during thier reproductive years. Between 40% and 50% of these women have recurrent episodes, and 5% to 8% experience chronic candida infections. Approximately 3 million women have recurrent candidial infections. The prevalence of vulvovaginitis candiasis is expected to rise due to the growing number of non-C albicans species (which are immune to most antifungal medcationa) and as a result of more widespread antifungal resistance.
authors.affiliation: University of Colorado Health Sciences Center, Denver, USA.
authors.forename: Candy
authors.initials: C
authors.lastname: Wilson
mesh_terms: D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001888:Boric Acids / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D015984:Causality; D000529:Complementary Therapies / Q000379:methods*; D011307:Drug Prescriptions; D025141:Drug Resistance, Fungal; D005260:Female; D005737:Garlic; D006801:Humans; D007779:Lactobacillus acidophilus; D004366:Nonprescription Drugs / Q000627:therapeutic use; D015995:Prevalence; D012008:Recurrence; D012648:Self Care; D020947:Tea Tree Oil / Q000627:therapeutic use; D016896:Treatment Outcome; D015014:Yogurt
chemical_list: D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D001888:Boric Acids; D004366:Nonprescription Drugs; D020947:Tea Tree Oil; C032688:boric acid